Related Experiment Video

Updated: May 12, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

Understanding alternative splicing of Cav1.2 calcium channels for a new approach towards individualized medicine

Ping Liao1, Tuck Wah Soong

  • 1National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore 308433.

Journal of Biomedical Research
|April 5, 2013
PubMed

Insights

Calcium channel blockers (CCBs) treat cardiovascular diseases by blocking calcium channels. Alternative splicing of Cav1.2 channels alters their sensitivity to CCBs, impacting disease outcomes and enabling personalized therapies.

Area of Science:

  • Cardiovascular Pharmacology
  • Molecular Biology
  • Genetics

Background:

  • Calcium channel blockers (CCBs) are essential for managing cardiovascular conditions like hypertension and angina.
  • CCBs function by inhibiting calcium ion influx through voltage-gated calcium channels, primarily Cav1.2, in the cardiovascular system.
  • Cav1.2 channels are crucial for cardiovascular function, and their structure influences CCB sensitivity.

Purpose of the Study:

  • To investigate the impact of alternative splicing on Cav1.2 channel structure and function.
  • To understand how Cav1.2 splice variants influence sensitivity to calcium channel blockers.
  • To explore the role of alternative splicing in cardiovascular disease pathogenesis and CCB response.

Main Methods:

  • Analysis of Cav1.2 channel alternative splicing in different cardiovascular tissues.
  • Pharmacological characterization of Cav1.2 splice variants with various CCBs.
  • Correlation of splicing patterns with disease phenotypes and treatment responses.

Main Results:

  • Extensive alternative splicing of Cav1.2 channels generates diverse functional variants.
  • Different splice variants exhibit altered sensitivity to calcium channel blockade.
  • Alternative splicing significantly modulates Cav1.2 channel gating properties and CCB interactions.
  • Cav1.2 splicing patterns are associated with specific cardiovascular disorders.

Conclusions:

  • Alternative splicing of Cav1.2 channels is a key determinant of their pharmacology and function in the cardiovascular system.
  • Understanding Cav1.2 splicing variations is critical for predicting CCB efficacy and side effects.
  • Targeting Cav1.2 splice variants holds promise for developing individualized cardiovascular therapies.

More Related Videos

Combining Optogenetics with Artificial microRNAs to Characterize the Effects of Gene Knockdown on Presynaptic Function within Intact Neuronal Circuits09:17

Combining Optogenetics with Artificial microRNAs to Characterize the Effects of Gene Knockdown on Presynaptic Function within Intact Neuronal Circuits

Published on: March 14, 2018

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry11:32

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry

Published on: September 28, 2016

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...